The impact of dark chocolate intake on arterial elasticity in individuals with HIV/AIDS undergoing ART: a randomized, double-blind, crossover trial

An increase in the frequency of cardiovascular diseases has been observed in the HIV/AIDS population. Studies involving healthy subjects or subjects with other diseases have shown benefits of chocolate supplementation on endothelial function and vasodilation. We evaluate the impact of chocolate cons...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Food & function 2017-06, Vol.8 (6), p.2212-2219
Hauptverfasser:	Teixeira, Andrea Mariana Nunes da Costa, Luzia, Liania Alves, de Souza, Suelen Jorge, de Almeida Petrilli, Aline, Pontilho, Patrícia de Moraes, de Souza, Jose Maria Pacheco, Segurado, Aluísio Augusto Cotrim, Efraim, Priscila, Picone, Camila de Melo, Rondo, Patrícia Helen de Carvalho
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired Immunodeficiency Syndrome - drug therapy Acquired Immunodeficiency Syndrome - physiopathology Acquired Immunodeficiency Syndrome - virology Adult Anti-HIV Agents - therapeutic use Arteries - physiopathology Blood Pressure - drug effects Cacao - metabolism Chocolate - analysis Double-Blind Method Female HIV Infections - drug therapy HIV Infections - metabolism HIV Infections - physiopathology HIV Infections - virology HIV-1 - genetics HIV-1 - isolation & purification HIV-1 - physiology Human immunodeficiency virus Humans Lentivirus Male Middle Aged Retroviridae Vasodilation - drug effects Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	An increase in the frequency of cardiovascular diseases has been observed in the HIV/AIDS population. Studies involving healthy subjects or subjects with other diseases have shown benefits of chocolate supplementation on endothelial function and vasodilation. We evaluate the impact of chocolate consumption on arterial elasticity in people living with human immunodeficiency virus - PLHIV. A double-blind, crossover trial including 110 PLHIV (19 to 59 years) on antiretroviral therapy - ART for at least 6 months and with a viral load of
ISSN:	2042-6496 2042-650X
DOI:	10.1039/c6fo01681b